Dimebon Slows Progression of Proteinopathy in γ-Synuclein Transgenic Mice

Intermediates and final products of protein aggregation play crucial role in the development of degenerative changes in a number of neurological diseases. Pathological protein aggregation is currently regarded as one of the most promising therapeutic targets for treatment of these diseases. Transgen...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Bachurin, Sergey O., Shelkovnikova, Tatyana A., Ustyugov, Alexey A., Peters, Owen, Khritankova, Ina, Afanasieva, Marina A., Tarasova, Tatyana V., Alentov, Igor I., Buchman, Vladimir L., Ninkina, Natalia N.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Springer-Verlag 2011
Gaiak:
Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC3351599/
https://ncbi.nlm.nih.gov/pubmed/22179976
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s12640-011-9299-y
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak